1 / 6

Liquid Biopsy Market 2020 High Growth, Market Share, Size, Demand, New Technology, Challenges and Trends Analysis till 2

Increasing cancer prevalence, preference for non-invasive diagnostics techniques and shift towards personalized medicines are the key factors driving the global liquid biopsy market.

MargaretsHill
Download Presentation

Liquid Biopsy Market 2020 High Growth, Market Share, Size, Demand, New Technology, Challenges and Trends Analysis till 2

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Adroit Market Research Global Liquid Biopsy Market Size 2018, by Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Risk of Recurrence), Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Other Cancers) Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA, Other Circulating Biomarkers), Region and Forecast 2019 to 2025 Single Use License: US$ 4400 Request Sample +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  2. Adroit Market Research Global Liquid Biopsy Market To Grow From USD 812 Million In 2018 To USD Global Liquid Biopsy Market To Grow From USD 812 Million In 2018 To USD 6,014 Million By 2025 6,014 Million By 2025 The global liquid biopsy market is anticipated to reach USD 6,014.2 million by 2025, growing at a CAGR of 33.4%. Increasing cancer prevalence is a prime factor driving the global liquid biopsy market. Adroit Market Research report on global liquid biopsy market gives a holistic view of the market from 2017 to 2025, which includes factors such as market drivers, restraints, opportunities, and challenges. The market has been studied for historic year 2017, with the base year of estimation as 2018 and forecast from 2019 to 2025. The report covers the current status and future traits of the market at global as well as country level along with the depiction of the industry’s value chain. In addition, the study also assesses the market based on Porter's five forces analysis. Noticeable players serving in the global liquid biopsy market have also been studied in detail. Liquid biopsy is a minimally invasive technique that can identify molecular biomarkers in blood and other body fluids. Mainly used for cancer, liquid biopsies allow for detection and analysis of circulating tumour material (cells or DNA) shed into the blood from the primary tumour and from metastatic sites. Current clinical applications of liquid biopsy include patient stratification and therapy selection, monitoring treatment response and drug resistance, disease prognosis and detection of disease recurrence. The global liquid biopsy market has been segmented based on applications, cancer type, and circulating biomarker types. Based on applications, the market is broken down into early cancer screening, therapy selection, treatment monitoring and risk of recurrence. Early cancer screening is expected to account nearly 50% market share by 2025. +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  3. Adroit Market Research Global Liquid Biopsy Market To Grow From USD 812 Million In 2018 To USD Global Liquid Biopsy Market To Grow From USD 812 Million In 2018 To USD 6,014 Million By 2025 6,014 Million By 2025 Asia Pacific is anticipated to be the fastest growing market through the forecast period. In this region rising income, increased urbanization, growing cancer cases, and government’s focus on healthcare facilities is driving the liquid biopsy market. However, there are substantial barriers to liquid biopsy adoption. A number of assays intended on high-cost next generation sequencing technology are not reimbursed, obstructing market uptake. Moreover, cost of the procedure is facilitating access to a larger population in India, Japan and China, which depend heavily on out-of-pocket expenditure. Worldwide, in the race of active clinical trials in liquid biopsy East Asia ranks second, while China bangs the maximum number of trials. Therefore, it is advised that companies must design and develop randomized controlled trials and inclusion in guidelines to encourage broader acceptance and favorable payer coverage in Asia Pacific. Major players operating in the global liquid biopsy market are Biocept, Inc., Qiagen N.V., Roche Diagnostics, Bio-Rad Laboratories, Inc., Myriad Genetics, Inc., Menarini-Silicon Biosystems, Trovagene, Inc., Guardant Health, Inc. and Genomic Health, Inc. among others. Browse the complete report on @ https://www.adroitmarketresearch.com/industry-reports/liquid-biopsy-market +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  4. Adroit Market Research Key segments of the global liquid Key segments of the global liquid biopsy market biopsy market Application Overview, 2017-2025 (USD Million) Early cancer screening Therapy selection Treatment monitoring Risk of recurrence Cancer Type Overview, 2017-2025 (USD Million) Lung cancer Breast cancer Colorectal cancer Prostate cancer Other cancers Circulating Biomarker Overview, 2017-2025 (USD Million) Circulating tumor cells (CTCs) Circulating tumor DNA (ctDNA) Other circulating biomarkers +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  5. Adroit Market Research Key segments of the global Key segments of the global liquid liquid biopsy biopsy market market Regional Overview, 2015-2025 (USD million) (Kilo tons) • North America • Europe • Asia Pacific • Central & South America • Middle East & Africa Purchase a single user copy of the global liquid biopsy market report@ https://adroitmarketresearch.com/researchreport/purchase/1413 +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

  6. Adroit Market Research About Us About Us Adroit Market Research is an India-based business analytics and consulting company. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps. Our analysts have tracked high growth markets in chemicals & materials, healthcare & pharmaceuticals, semiconductor & electronics, energy & power, food & retail, consumer goods, technology, and machinery & equipment sectors across the world to identify new opportunities, potential customers, prepare go-to-market (GTM) strategies, identify segments for revenue growth for companies, and manymore. Contact Us US Headquarters Phone: +1 (214) 884-6068 Email: sales@adroitmarketresearch.com 3131 McKinney Ave Ste 600 Dallas, TX 75204 ,U.S.A +1 (214) 884-6068 sales@adroitmarketresearch.com www.adroitmarketresearch.com

More Related